XML 17 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
OPERATING ACTIVITIES    
Net income including non-controlling interests $ 25,712 $ 23,332
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation and amortization 6,210 5,656
Provision for doubtful accounts 2,962 3,119
Equity-based awards compensation expense 3,748 3,368
Loss (gain) on sale of fixed assets 31 3
Excess tax benefit from equity-based awards (798) (816)
Deferred income tax 5,688 3,181
Other 0 180
Changes in operating assets and liabilities:    
Increase in patient accounts receivable (2,548) (4,148)
Decrease (increase) in accounts receivable - other 116 (145)
Increase in other assets (4,979) (1,485)
Increase (decrease) in accounts payable and accrued expenses 5,178 (3,766)
Increase in other liabilities 708 380
Net cash provided by operating activities 42,028 28,859
INVESTING ACTIVITIES    
Purchase of fixed assets (5,620) (4,690)
Purchase of businesses, net of cash acquired (12,958) (14,434)
Acquisitions of non-controlling interests (including redeemable non-controlling interests) (1,800) (2,802)
Proceeds on sale of fixed assets, net 42 71
Net cash used in investing activities (20,336) (21,855)
FINANCING ACTIVITIES    
Distributions to non-controlling interests (including redeemable non-controlling interests) (8,271) (6,836)
Cash dividends to shareholders - funded (6,382) (5,586)
Proceeds from revolving line of credit 128,000 75,000
Payments on revolving line of credit (136,000) (63,500)
Principal payments on notes payable (592) (616)
Tax benefit from equity-based awards 798 816
Other 1 5
Net cash used in financing activities (22,446) (717)
Net (decrease) increase in cash and cash equivalents (754) 6,287
Cash and cash equivalents - beginning of period 15,778 14,271
Cash and cash equivalents - end of period 15,024 20,558
Cash paid during the period for:    
Income taxes 10,051 5,659
Interest 770 616
Non-cash investing and financing transactions during the period:    
Purchase of business - seller financing portion 514 1,240
Acquisition of noncontrolling interest - seller financing portion 500 1,350
Revaluation of redeemable non-controlling interests 0 627
Sale of non-controlling interests $ (148) $ 0